We first sorted defined subsets of LHSCs (Lin−CD34+CD45+) and LVSELs (Lin−CD34+CD45−) from untreated and treated CD34+ SCs isolated from patients affected by CML and not receiving TKI. Here, PTPRC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.